Every child born in the United States is today screened for diseases at birth, though the range of testing is not uniform, it varies from state to state. In India, we are very far from such screening but I believe, at individual levels, it will become commonplace soon. More than 70 percent of healthcare is in private sector and in the absence of universal coverage individual choices prevail, particularly when direct-to-consumer companies are getting aggressive.
Even if we take clinician-mediated genomic testing, Strand Life Sciences alone has expanded its exome sequencing services from one hospital at the beginning of the year to more than 20 as the year closes.
So what choices can individuals make when they get their genome (exome in the foreseeable future) sequenced?
Read the full, original story here: Life in the Time of Genetic Decoding – Part III
